Amycolatopsis rifamycinica 拉丁名
(ATCC® 21789™) 统一编号
Deposited As Streptomyces mediterranei Margalith and Beretta
Strain Designations 菌株别名 M 18
Application 用途 Produces rifamycin B nancimycin
Biosafety Level 生物安全等级 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式freeze-dried
Preceptrol® no
Type Strain 模式菌株 no
Medium 培养基 ATCC® Medium 1877: ISP Medium 1
ATCC® Medium 196: Yeast malt extract agar
Growth Conditions 生长条件
Temperature 培养温度: 26.0℃
Name of Depositor 寄存人 Gruppo Lepetit S.p.A. U.S. Patent Number 3,843,449
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
References 参考文献 White RJ, Lancini G. Production of rifamycin B.
US Patent 3,871,965 dated Mar 18 1975 Lechevalier MP, et al. Two new genera of nocardioform Actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov.. Int. J. Syst. Bacteriol. 36: 29-37, 1986. Bala S, et al. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.. Int. J. Syst. Evol. Microbiol. 54: 1145-1149, 2004. PubMed: 15280283
